Dr. Iqbal on the Biggest Advance in the Treatment of Neuroendocrine Tumors
November 6th 2018
Syma Iqbal, MD, associate professor of clinical medicine, Keck School of Medicine, University of Southern California, discusses the impact of peptide receptor radionuclide therapy (PRRT) on the treatment of patients with neuroendocrine tumors (NETs).